Claire Thomas
Directeur/Membre du Conseil chez REBUS HOLDINGS, INC.
Fortune : - $ au 31/12/2023
Postes actifs de Claire Thomas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REBUS HOLDINGS, INC. | Directeur/Membre du Conseil | 12/10/2016 | - |
| Independent Dir/Board Member | 12/10/2016 | - | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Claire Thomas
Anciens postes connus de Claire Thomas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31/07/2013 | 30/06/2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2008 | 01/01/2013 |
Formation de Claire Thomas
| University of Illinois | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Claire Thomas
- Expérience
